Gilead shares rise after United States approves remdesivir as COVID-19 drug - Reuters UK

3:42am PDT - October 23rd, 2020    veterans day - Reuters

Shares of Gilead Sciences Inc rose 6% on Friday after its antiviral drug, remdesivir, became the first and only approved treatment for COVID-19 in the United States.